Profile photo Helena Verkooijen

Helena Verkooijen

Full Professor

Strategic program(s):

Biography

Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology. 
Medical-scientific director of the Imaging Cluster (incorporating the departments of Radiology, Radiotherapy, Nuclear Medicine and Clinical Physics) at the Antoni van Leeuwenhoek hospital. Leader (PI) of several international research consortia and academic industrial partnership, based at UMC Utrecht. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, panel member, and member of the supervisory board of the Rotterdam Eye Hospital. 
Sharp analytic mind, strong drive and ability to turn ideas into reality. Connector. Passionate about encouraging and facilitating colleagues, team members, and (PhD) students to bring out the best in themselves and each other.

Strategic program(s):

Contact

Research groups

Evaluation of imaging and image-guided Interventions

Research aim

The pace of innovation in (AI driven) imaging/image-guided interventions in oncology is high; the window of opportunity for evaluation narrow. We aim to learn from every patient, in order to facilitate evidence-based implementation of innovation.

Go to group

Recent publications

Attitudes toward AI-generated risk prediction in patients with early breast cancer Frederik Voigt Carstensen, Sofie A M Gernaat, Friederike Banning, Eva Batista, Desiree Van den Bongard, Nadia Harbeck, Marle Hattink, Lorenzo Livi, Icro Meattini, Karin Meijer, Jens Petersen, Ivica Ratosa, Helena Verkooijen, Ivan Richter Vogelius, Maja Vestmø Maraldo
Acta Oncologica, 2025, vol. 64, p.1125-1128
Response to Yuan, Zheng, and Zang Claudia A. Bargon, Dieuwke R. Mink Van Der Molen, Danny A. Young-Afat, Annemiek Doeksen, Helena M. Verkooijen
Journal of the National Cancer Institute, 2025, vol. 117, p.1753-1755
From European Standards to Responsible Use of AI in Clinical Practice Roosmarie Jessen, Marieke A.R. Bak, Catelijne C.J. Muller, Helena M. Verkooijen, Kak Khee Yeung, M. Corrette Ploem
European journal of health law, 2025, vol. 32, p.111-138
Impact of Pain Education on Pain Relief in Oncological Patients Erika Galietta, Costanza M. Donati, Alberto Bazzocchi, Rebecca Sassi, Arina A. Zamfir, Renée Hovenier, Clemens Bos, Nikki Hendriks, Martijn F. Boomsma, Mira Huhtala, Roberto Blanco Sequeiros, Holger Grüll, Simone Ferdinandus, Helena M. Verkooijen, Alessio G. Morganti
Cancers, 2025, vol. 17
Interrater Agreement in Assessment of Eligibility for Magnetic Resonance–Guided High-Intensity Focused Ultrasound of Patients with Painful Bone Metastases Renée Hovenier, Clemens Bos, Martijn F. Boomsma, Holger Grüll, Alessio G. Morganti, Helena M. Verkooijen,
Journal of Vascular and Interventional Radiology, 2025, vol. 36, p.917-921.e4
Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Therapy J M Westerhoff, J C M Scheepens, F F van Wolffelaar, U Bernchou, R Bahij, B Erickson, J P Christodouleas, S S W Ng, C Gani, A Choudhury, F Alongi, P Renz, A T Colonias, G J Meijer, T Schytte, M P W Intven, H M Verkooijen, L A Daamen, W A Hall
International journal of radiation oncology, biology, physics, 2025, vol. 122, p.698-708

External positions

Lid raad van toezicht - Toezicht - BCN / Alexander Monro Ziekenhuis

Lid raad van toezicht - Toezicht - Oogziekenhuis Rotterdam

Lid Commissie Exploratie - Beoordeling wetenschappelijke aanvragen - KWF Kankerbestrijding

bestuurslid - geen - JM Fentener van Vlissingen Fonds

Spreker - ja - Elekta

Lid Wetenschappelijke Adviesraad Landelijk ReferentieCentrum Bevolkingsonderzoek - inhoudelijk - LRCB